Andrew Taylor to Fibrosis
This is a "connection" page, showing publications Andrew Taylor has written about Fibrosis.
Connection Strength
2.053
-
Taylor AJ, Warren J. Diastolic Function and Fibrosis Burden: Improving Prognostication in Heart?Failure. JACC Cardiovasc Imaging. 2023 06; 16(6):797-799.
Score: 0.209
-
Voskoboinik A, Costello BT, La Gerche A, Prabhu S, Wong G, Flannery MD, Nalliah C, Sugumar H, Springer F, Kalman JM, Taylor AJ, Kistler PM. Relation of Alcohol Consumption to Left Ventricular Fibrosis Using Cardiac Magnetic Resonance Imaging. Am J Cardiol. 2019 02 01; 123(3):460-465.
Score: 0.154
-
Costello BT, Qadri M, Price B, Papapostolou S, Thompson M, Hare JL, La Gerche A, Rudman M, Taylor AJ. The ventricular residence time distribution derived from 4D flow particle tracing: a novel marker of myocardial dysfunction. Int J Cardiovasc Imaging. 2018 Dec; 34(12):1927-1935.
Score: 0.150
-
Costello BT, Springer F, Hare JL, Gerche A, Iles L, Ellims AH, Schmitt B, Taylor AJ. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3?T. Int J Cardiovasc Imaging. 2017 Oct; 33(10):1551-1560.
Score: 0.139
-
Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016 Jan; 9(1):67-81.
Score: 0.126
-
Ngu PJ, Butler M, Pham A, Roberts SK, Taylor AJ. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease. Int J Cardiovasc Imaging. 2016 Apr; 32(4):629-36.
Score: 0.126
-
Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, Hare JL, Kaye DM, Marasco SF, McLean CA, James PA, du Sart D, Taylor AJ. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Eur Heart J Cardiovasc Imaging. 2014 Oct; 15(10):1108-16.
Score: 0.113
-
Ellims AH, Shaw JA, Stub D, Iles LM, Hare JL, Slavin GS, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol. 2014 Mar 25; 63(11):1112-8.
Score: 0.111
-
Ling LH, Kalman JM, Ellims AH, Iles LM, Medi C, Sherratt C, Kaye DM, Hare JL, Kistler PM, Taylor AJ. Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation. Circ Arrhythm Electrophysiol. 2013 Aug; 6(4):697-704.
Score: 0.107
-
Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, Kalman JM, Kaye DM, Taylor AJ. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol. 2012 Dec 11; 60(23):2402-8.
Score: 0.101
-
Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012 Oct 29; 14:76.
Score: 0.101
-
Chan W, Duffy SJ, White DA, Gao XM, Du XJ, Ellims AH, Dart AM, Taylor AJ. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging. 2012 Sep; 5(9):884-93.
Score: 0.100
-
Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011 Feb 15; 57(7):821-8.
Score: 0.090
-
Kaye DM, Iles L, Taylor AJ. Myocardial fibrosis in hypertrophic cardiomyopathy. N Engl J Med. 2010 11 11; 363(20):1971; author reply 1971.
Score: 0.088
-
Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008 Nov 04; 52(19):1574-80.
Score: 0.077
-
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.
Score: 0.054
-
Prabhu S, Costello BT, Taylor AJ, Gutman SJ, Voskoboinik A, McLellan AJA, Peck KY, Sugumar H, Iles L, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Lee G, Mariani J, Kaye DM, Ling LH, Kalman JM, Kistler PM. Regression of Diffuse Ventricular Fibrosis?Following Restoration of Sinus?Rhythm With Catheter Ablation in?Patients With Atrial Fibrillation and?Systolic Dysfunction: A Substudy of the CAMERA MRI Trial. JACC Clin Electrophysiol. 2018 08; 4(8):999-1007.
Score: 0.037
-
McLELLAN AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ, Kistler PM. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. J Cardiovasc Electrophysiol. 2016 05; 27(5):571-80.
Score: 0.032
-
Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015 Sep 24; 13:314.
Score: 0.031
-
McLellan AJ, Ling LH, Azzopardi S, Ellims AH, Iles LM, Sellenger MA, Morton JB, Kalman JM, Taylor AJ, Kistler PM. Diffuse ventricular fibrosis measured by T1 mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2014 Oct; 7(5):834-40.
Score: 0.029
-
Fang L, Beale A, Ellims AH, Moore XL, Ling LH, Taylor AJ, Chin-Dusting J, Dart AM. Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy. J Am Heart Assoc. 2013 Oct 14; 2(5):e000270.
Score: 0.027
-
Ling LH, Taylor AJ, Ellims AH, Iles LM, McLellan AJ, Lee G, Kumar S, Lee G, Teh A, Medi C, Kaye DM, Kalman JM, Kistler PM. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013 Sep; 10(9):1334-9.
Score: 0.027
-
La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidb?chel H, Prior DL. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012 Apr; 33(8):998-1006.
Score: 0.024